$165-175k
OTE
$140-150k
BASE
+ Company Stock Options
Pet pharmacy
Open for applications
$165-175k
OTE
$140-150k
BASE
+ Company Stock Options
21-100 employees
Creating custom medications and delightful experiences for pets, their parents and veterinarians.
Desirable
The pharmacy experience has dramatically changed in recent years with the advent of at-home delivery. However the veterinary side of the industry is not keeping up with these developments.
Mixlab is modernising the pharmacy experience for vets and our pets. Veterinarians that use Mixlab’s digital service can streamline their daily medication workflow, giving them more time to spend on actual patients.
The startup is now going further than just delivery and administrative streamlining and is making its own medications on-demand that are flavored and dosed. It's in this vein that the company wants to continue to expand - providing a pharmaceutical service that humans would be jealous of.
It's an impressive ambition but ultimately will rely on the trust of its veterinarian customers. So far, in this respect Mixlab has delivered, with a 50% increase in sales over 2023 as well as enjoying a $10 million extension of its Series A funding. This will be channeled into opening new locations in the Miami area and bringing its new medications and over-the-counter wellness products to market. With the company nearing profitability, it's clear that Mixlab's bite matches its bark.
Kirsty
Company Specialist at Welcome to the Jungle
-9% employee growth in 12 months
Aug 2023
$10m
SERIES A
Aug 2021
$20m
SERIES A
Garment District, New York, NY
Frederic Dijols
(CEO)Previously an Associate at J.P. Morgan. Earned an MBA from Harvard Business School. Prior to that, worked as a Senior R&D Engineer at Johnson & Johnson.
Share this job